Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report

BACKGROUND: Patients on dialysis are at higher risk of major bleeding and recurrent thrombosis creating acute venous thromboembolism (VTE) treatment challenges. DOACs represent an interesting option but there are concerns of bioaccumulation and increased bleeding risk. Anti-Xa trough levels may be u...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberge, Guillaume, Wells, Philip Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017605/
https://www.ncbi.nlm.nih.gov/pubmed/33794913
http://dx.doi.org/10.1186/s12959-021-00277-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017605/
https://www.ncbi.nlm.nih.gov/pubmed/33794913
http://dx.doi.org/10.1186/s12959-021-00277-8

Ejemplares similares